Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock

71.65 EUR
-0.01 (-0.01%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to EWL. EWL was compared to 68 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings would make EWL suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • Each year in the past 5 years EWL has been profitable.
  • EWL had a positive operating cash flow in each of the past 5 years.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • EWL has a better Return On Assets (10.31%) than 88.24% of its industry peers.
  • With a decent Return On Equity value of 13.40%, EWL is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • The Return On Invested Capital of EWL (9.83%) is better than 75.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.73%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • EWL has a better Profit Margin (23.25%) than 91.18% of its industry peers.
  • EWL's Profit Margin has improved in the last couple of years.
  • EWL has a Operating Margin of 27.73%. This is amongst the best in the industry. EWL outperforms 95.59% of its industry peers.
  • EWL's Operating Margin has been stable in the last couple of years.
  • EWL has a Gross Margin of 78.19%. This is amongst the best in the industry. EWL outperforms 92.65% of its industry peers.
  • EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

  • EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • EWL has less shares outstanding than it did 1 year ago.
  • EWL has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EWL has an improved debt to assets ratio.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 12.25 indicates that EWL is not in any danger for bankruptcy at the moment.
  • EWL's Altman-Z score of 12.25 is amongst the best of the industry. EWL outperforms 95.59% of its industry peers.
  • The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.75, EWL belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of EWL (0.06) is better than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.25
ROIC/WACC0.99
WACC9.9%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 4.00 indicates that EWL has no problem at all paying its short term obligations.
  • EWL's Current ratio of 4.00 is amongst the best of the industry. EWL outperforms 91.18% of its industry peers.
  • A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
  • EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • EWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
  • EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.40% on average over the next years. This is quite good.
  • Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.47% on average per year.
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.42, the valuation of EWL can be described as expensive.
  • EWL's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.30. EWL is around the same levels.
  • With a Price/Forward Earnings ratio of 28.28, EWL can be considered very expensive at the moment.
  • EWL's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of EWL to the average of the S&P500 Index (24.04), we can say EWL is valued inline with the index average.
Industry RankSector Rank
PE 32.42
Fwd PE 28.28
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EWL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EWL is more expensive than 61.76% of the companies in the same industry.
  • EWL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 60.6
EV/EBITDA 24.64
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)21.44
PEG (5Y)4.55
EPS Next 2Y6.17%
EPS Next 3Y7.9%

0

5. Dividend

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

EDWARDS LIFESCIENCES CORP

FRA:EWL (1/13/2026, 7:00:00 PM)

71.65

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap41.58B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target81.68 (14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)0%
PT rev (3m)6.59%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0.07%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 32.42
Fwd PE 28.28
P/S 8.24
P/FCF 60.6
P/OCF 47.65
P/B 4.75
P/tB 6.63
EV/EBITDA 24.64
EPS(TTM)2.21
EY3.08%
EPS(NY)2.53
Fwd EY3.54%
FCF(TTM)1.18
FCFY1.65%
OCF(TTM)1.5
OCFY2.1%
SpS8.7
BVpS15.09
TBVpS10.8
PEG (NY)21.44
PEG (5Y)4.55
Graham Number27.39
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.25
F-Score6
WACC9.9%
ROIC/WACC0.99
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.27%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.42 and the Price/Book (PB) ratio is 4.75.